-- Mary Elizabeth Dallas
SUNDAY, March 30, 2014 (HealthDay News) -- Though more study
needs to be done, new research suggests that a simple blood test
could help predict the heart attack risk of patients experiencing
The Swedish study found that patients with chest pain who have
undetectable levels of a certain chemical signal in their blood
called "high-sensitivity cardiac troponin T," plus no sign of
reduced blood flow, are at very low risk for heart attack over the
The authors of the study, which is to be presented Sunday in
Washington, D.C., at the annual meeting of the American College of
Cardiology, believe the test could help prevent many unnecessary
"Chest pain is a potentially life-threatening symptom, as well as being a very common one," study lead author Dr. Nadia Bandstein, from the Karolinska Institute in Solna, Sweden, said in a meeting news release. "In our hospital it's the second most common symptom reported in the emergency department. Since there are no established ways to quickly rule out heart attack, many patients are admitted to the hospital unnecessarily, at a large cost to the patient and to society."
According to Bandstein, "using this blood test along with an ECG
[electrocardiogram], we will save about 500 to 1,000 admissions per
year in our hospital alone, allowing us to use the beds for sicker
Still, more research is required. And experts note that studies
presented at medical meetings are typically considered preliminary
until published in a peer-reviewed journal.
As the researchers explained, high-sensitivity cardiac troponin
T is a chemical signal in the blood that can help doctors detect
heart damage. It is a relatively new factor used to diagnose heart
attack and can be detected in the blood several hours before older
methods of measuring troponins.
In conducting the study, Bandstein's team analyzed blood levels
of this chemical signal in almost 15,000 patients who visited
emergency rooms in Sweden from 2010 to 2012. They focused on more
than 8,900 patients with undetectable levels of troponin who also
had no signs of heart damage from reduced blood flow. These
patients averaged 47 years of age.
The researchers then examined how many of these patients went on
to suffer a heart attack within 30 days. During that time, only 39
of the patients included in the study had a heart attack, the
researchers reported. Of these, 15 had no signs of damage due to
reduced blood flow.
Overall, only one in every 594 patients who go to the emergency
room for chest pain with no sign of heart damage and undetectable
levels of troponin are at immediate risk for heart attack, the
The study found a 99.8 percent probability that this subset of
patients was not at risk for heart attack and a 100 percent
probability that it wasn't at risk for death. This was true even
after other risk factors for heart disease and how long the
patients experienced symptoms were considered.
"Despite our observations before the study, we were still surprised by the strength of our findings," Bandstein noted.
Current guidelines recommend that high-sensitivity cardiac
troponin T be tested at least three hours after chest pain begins.
This usually means patients must be admitted to the hospital. The
study's authors said their findings suggest that only one testing
would be needed, which could prevent some unnecessary hospital
Two U.S. heart experts said the study gives support to the
validity of the blood test.
"This study provides increasing evidence for the selective use of high-sensitivity cardiac troponin T to help evaluate patients with chest pain for evidence of possible heart attack," said Dr. Robert Glatter, an emergency medicine physician at Lenox Hill Hospital in New York City.
He did have two caveats, however: First, that more study is
needed to validate the accuracy of the test. And second, that a
small minority of patients did go on to suffer a heart attack in
the month after a good test result.
"This is important to know because having a single normal or negative troponin [test result] initially does not completely remove all risk of suffering a heart attack after discharge from the emergency department," Glatter said.
While the results are promising, ruling out heart attack or
angina (heart-linked chest pain) in high-risk patients with a prior
history of diabetes, heart disease, or prior cardiovascular care
"may be problematic based on one blood sample alone," he added.
"The entire picture of the nature of the chest pain as well as
other presenting symptoms must be taken into consideration."
Dr. Sripal Bangalore is director of research in the Cardiac
Catheterization Laboratory at NYU School of Medicine in New York
City. He said the study is "compelling, given the large number of
patients included, and shows that a simple blood test combined with
the ECG can potentially avoid thousands of hospital admissions
every day for patients presenting with chest pain."
But, Bangalore added that "one should be very careful, however,
not to conclude that the opposite is true, [that is,] if you have
elevated high-sensitive troponin you are having a heart attack, as
there is data to suggest that it is elevated after running a
marathon," for example.
The U.S. National Heart, Lung, and Blood Institute provides more
heart attack risk factors.
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.